HeyJaredKeith Speights
- Indexed articles, last 90 days
- 25
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Aol
- Top 5K sites
- Earliest in this view
- Aug 29, 2026
Latest articles
Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer. - AOL (opens the original)
Read excerpt
Twenty-four of 32 analysts covering Intuitive Surgical rate the stock as a "buy" or "strong buy." However, Intuitive faces multiple headwinds that are pressuring its growth. While these headwinds are real, the company's tailwinds should be stronger over the long run. 10 stocks we like better than Intuitive Surgical › Count Intuitive Surgical(NASDAQ: ISRG) among the biggest healthcare losers of 2026. The medical device stock is down close to 30% year to date. Its performance was even worse. By la
Every Market Crash Warning Signal Is Flashing Red — and the S&P 500 Is Up 12% Anyway. History Says the Alarmists Are Wrong More Often Than You Think. - AOL (opens the original)
Read excerpt
Market valuation metrics and margin debt levels are at historically high levels. These have been indicators of major market sell-offs in the past. However, history also shows that these metrics can flash red while the stock market continues to climb. These 10 stocks could mint the next wave of millionaires › Should investors be worried right now? If you consulted a Magic 8 Ball, it might respond: "Signs point to yes." Practically every market crash warning signal is currently flashing red. Meanw
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right. - AOL (opens the original)
Read excerpt
Wall Street analysts are overwhelmingly bullish about Alnylam. The stock's attractive valuation and the company's growth prospects appear to support their enthusiasm. There are a couple of things to watch with Alnylam, though, that could change the outlook for its stock. 10 stocks we like better than Alnylam Pharmaceuticals › There's good news and bad news if you own shares of Alnylam Pharmaceuticals(NASDAQ: ALNY). The good news is that the biotech stock is up around 25% since the end of July. T
Why I Just Bought This 8%-Yielding S&P 500 ETF - AOL (opens the original)
Read excerpt
The Goldman Sachs S&P 500 Premium Income ETF sells call options to generate monthly income. This ETF is well-suited to the market's current high volatility. It has also captured most of the S&P 500's total return year to date. 10 stocks we like better than Goldman Sachs ETF Trust - Goldman Sachs S&P 500 Premium Income ETF › Which asset should most investors put their money into? Warren Buffett has recommended buying and holding an S&P 500(SNPINDEX:^GSPC) index fund. He has even advised this appr
Anthropic and OpenAI Are Both Racing to IPO. GE Vernova Wins Either Way. - AOL (opens the original)
Read excerpt
Anthropic and OpenAI are consuming tremendous amounts of electricity. That's great news for GE Vernova, which makes turbines and other equipment used in producing electricity. GE Vernova's stock's lofty valuation is arguably justified by its booming business. 10 stocks we like better than GE Vernova › Two of the hottest artificial intelligence (AI) companies on the planet plan to go public. Anthropic filed a confidential S-1 initial registration statement with the U.S. Securities and Exchange Co
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For Aol, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.